Larvol Delta - Palladio-Biosciences-Announces-Presentation-of-Data-from-a-Study-of-Lixivaptan-Use-in-an-ADPKD-Patient-who-Previously-Experienced-Liver-Toxicity-with-Tolvaptan-During-the-American-Society-of-Nephrology-Kidney-Week-2020-Meeting

Lixar (lixivaptan) - Palladio

https://www.businesswire.com/news/home/20201020005214/en/Palladio-Biosciences-Announces-Presentation-of-Data-from-a-Study-of-Lixivaptan-Use-in-an-ADPKD-Patient-who-Previously-Experienced-Liver-Toxicity-with-Tolvaptan-During-the-American-Society-of-Nephrology-Kidney-Week-2020-Meeting

Oct 20, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next